Editorial: Next-Generation Alzheimer's Therapeutics: Leveraging Deep Biology. | J Prev Alzheimers Dis;7(3): 138-139, 2020. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Editorial: Next-Generation Alzheimer's Therapeutics: Leveraging Deep Biology.

Longo, F M; Massa, S M.

Affiliation

Longo FM; Frank M. Longo, Department of Neurology and Neurological Sciences, Stanford University, USA, flongo@stanford.edu.

J Prev Alzheimers Dis ; 7(3): 138-139, 2020.

Article in En | MEDLINE | ID: mdl-32463062

Subject(s)

Alzheimer Disease/drug therapy; Amyloid beta-Peptides/antagonists & inhibitors; Alzheimer Disease/metabolism; Alzheimer Disease/physiopathology; Drug Development/trends; Humans; Molecular Targeted Therapy/trends; Research Design

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Amyloid beta-Peptides / Alzheimer Disease Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Prev Alzheimers Dis Year: 2020 Document type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Amyloid beta-Peptides / Alzheimer Disease Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Prev Alzheimers Dis Year: 2020 Document type: Article